How do you indentify a toxicity being related to the axitnib or the pembrolizumab?
Michael B. Atkins, MD Deputy Director Professor, Oncology & Medicine Georgetown Lombardi Comprehensive Cancer Center answers How do you indentify a toxicity being related to the axitnib or the pembrol...
Author: Cancer-News
Added: 04/03/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts